logo
Tata Motors Ltd.
12 Aug 2026
425.50
-0.83%
Tata Motors Ltd - 544569 - Outcome Of The Board Meeting - Results
BSE India
Pursuant to Regulation 33 and 52 and other applicable Regulations of the SEBI Listing Obligations read with Schedule III thereof, we hereby inform you that the Board of Directors of the Company at its meeting held today, August 12, 2026, has approved the Audited Standalone Financial Results along with Auditors Report thereon and the Unaudited Consolidated Financial Results alongwith the Limited Review Report thereon, for the first quarter ended June 30, 2026.
Chemtech Industrial Valves Ltd - 537326 - Board Meeting Outcome for Outcome Of Board Meeting Held …
BSE India
Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations, 2015") and our letter dated August 05, 2026, this is to inform you that the Board of Directors of the Company at its Meeting held on Wednesday, August 12, 2026 has inter-alia, considered and approved Unaudited Financial Results of the Company for the Quarter ended June 30, 2026, as reviewed and recommended by the Audit Committee and took note of the Limited Review Report thereon, submitted by Statutory Auditor of the Company, M/s. Raju & Prasad, Chartered Accountants in terms of Regulation 33 of SEBI LODR Regulations, 2015.
ISL Consulting Ltd - 511609 - Board Meeting Outcome for Outcome Of Board Meeting Held On …
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company in its meeting held today i.e., on Wednesday, August 12, 2026, from 03:00 PM to 03:37 PM at the registered office of the Company, inter alia, has: Considered and approved the Un-Audited Standalone Financial Results for the quarter ended on June 30, 2026 along with the Limited Review Report thereon, with unmodified opinion, as per Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Prism Medico and Pharmacy Ltd - 512217 - Board Meeting Outcome for Outcome Of The Board …
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August, 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June, 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
5.50
4.96%